Future Science Group

Mar 31 2025 290 ep. 16 mins 385
Future Science Group Podcast artwork

Podcast by Taylor & Francis Group

  Science
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Unveiling bioanalytical datasets for the successful development of ADCs

Mar 31 2025 19 mins  
Unveiling bioanalytical datasets for the successful development of ADCs

Bridging science and safety: exploring toxicology studies and regulatory requirements

Mar 27 2025 10 mins  
Bridging science and safety: exploring toxicology studies and regulatory requirements

Cell therapies for autoimmune diseases: a podcast with Lindsay Davies

Feb 19 2025 13 mins  
This International Women’s Day, we’re joined by Lindsay Davies, Chief Scientific Officer at NextCell Pharma (Stockholm, Sweden), to discuss the evolving role of cell therapies in treating autoimmune diseases. In this podcast, Davies breaks down the science behind NextCell’s mesenchymal stromal cell therapy for type 1 diabetes and explores how these cells could be applied to

The use of GenAI in bioanalysis: an interview with Priyata Kalra

Feb 06 2025 28 mins  
During the American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 2024 conference, Bioanalysis Zone caught up with industry experts across numerous disciplines to discuss their involvement with AAPS and their research. In this interview, we spoke to Priyata Kalra about her talk on the use of GenAI within biomedicine.

The need for HRMS for quantitation of ADCs vs. QQQ: an interview with Megan Cooley

Jan 09 2025 21 mins  
In this episode, we sit down with Megan Cooley, Associate Director of Bioanalytical Services at ICON (KS, USA), to explore the cutting-edge world of antibody-drug conjugate (ADC) quantitation using high-resolution mass spectrometry (HRMS). Megan delves into the capabilities of Triple Quadrupole and Time-of-Flight mass spectrometry, offering her expert insights into whether HRMS is

How can medical device regulation catch up with innovation?

Dec 16 2024 12 mins  
In this interview, we discuss the potential of AI in increasing healthcare system efficiency, how medical devices are making procedures less invasive and what those working in the field of medical devices can do to help regulation catch up with innovation.

The new frontier: assessing efficacy and safety of CGTs using biomarkers

Sep 27 2024 24 mins  
In the sixth episode of The new frontier podcast, we're joined by Catherine Vrentas, Life Sciences Lead at Booz Allen Hamilton (VA, USA). Cathy explains how biomarkers can be used to predict the therapeutic outcome and efficacy of CGTs and the biomarkers in particular that have shown strong predictive value. We delve into the common challenges of working with biomarkers in CGTs and

Carlon Fitzpatrick AI Summit

Sep 11 2024 3 mins  
Carlon Fitzpatrick AI Summit by Taylor & Francis Group

Challenges and solutions in monitoring assay performance for vaccine development

Jul 31 2024 18 mins  
Challenges and solutions in monitoring assay performance for vaccine development: an interview with Atul Chaudhari

ADA detection and characterization for immunogenicity testing: insights from ICON's Lindsay Denhoff

Jul 09 2024 11 mins  
We caught up with Principal Scientist Lindsay Denhoff (ICON; Dublin, Ireland) to discuss immunogenicity considerations for therapeutic proteins and the current analytical methodologies for detecting and characterizing anti-drug antibodies (ADAs). Lindsay shares some industry best practices for achieving high-quality ADA assays, as well as some of the advantages and limitations of s